Cue Biopharma, Inc.
Cue Biopharma, Inc. (CUE) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 117 transactions totaling $9.9M, demonstrating a bullish sentiment with $2.0M in net insider flow. The most recent transaction on Aug 25, 2023 involved a purchase of 4,000 shares valued at $11.0K.
CUE Insider Activity Summary
Who Is Buying CUE Stock?
No significant insider buying has been recorded for CUE in the recent period.
Who Is Selling CUE Stock?
No significant insider selling has been recorded for CUE in the recent period.
Is Cue Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CUE is bullish with an Insider Alignment Score of 60/100 and a net flow of $2.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CUE Frequently Asked Questions
Understanding CUE Insider Activity
Insider trading at Cue Biopharma, Inc. (CUE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading CUE stock, having executed 117 transactions in the past 90 days. The most active insider is Aaron G.l. Fletcher (Executive), who has made 6 transactions totaling $4.5M.
Related Tools
Track Cue Biopharma, Inc. Insider Activity
Get notified when executives and directors at CUE file new Form 4 transactions